Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study

被引:83
作者
Chubb, S. A. Paul [2 ,3 ]
Hyde, Zoe [3 ]
Almeida, Osvaldo P. [3 ,4 ]
Flicker, Leon [5 ]
Norman, Paul E. [6 ]
Jamrozik, Konrad [7 ]
Hankey, Graeme J. [5 ]
Yeap, Bu B. [1 ,5 ]
机构
[1] Fremantle Hosp, Sch Med & Pharmacol, Dept Endocrinol, Fremantle, WA 6160, Australia
[2] Fremantle Hosp, Dept Biochem, Fremantle, WA 6160, Australia
[3] Univ Western Australia, WA Ctr Hlth & Aging, Perth, WA 6009, Australia
[4] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia
[5] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia
[6] Univ Western Australia, Sch Surg & Pathol, Perth, WA 6009, Australia
[7] Univ Adelaide, Sch Populat Hlth & Clin Practice, Adelaide, SA 5005, Australia
关键词
D O I
10.1530/EJE-07-0893
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Reduced circulating testosterone and sex hormone-binding globulin (SHBG) Eire implicated as risk factors for metabolic syndrome. As SHBG increases with age while testosterone declines, we examined the relative contributions of SHBG and testosterone to the risk of metabolic syndrome in older men. Methods: We conducted a cross-sectional study of 2502 community-dwelling men aged >= 70 years without known diabetes. Metabolic syndrome was defined using the National Cholesterol Education Program-Third Adult Treatment Panel (NCEP-ATPIII) criteria. Early morning fasting sera were assayed for total testosterone, SHBG and LH. Free testosterone was calculated using mass action equations. Results: There were 602 men with metabolic syndrome (24.1%). The risk of metabolic syndrome increased for total testosterone < 20 nmol/l, SHBG < 50 nmol/l and free testosterone < 300 pmol/l. In univariate analyses SHBG was associated with all five components of metabolic syndrome, total testosterone was associated with all except hypertension, and free testosterone was associated only with waist circumference and triglycerides. In multivariate analysis, both total testosterone and especially SHBG remained associated with metabolic syndrome. with odds ratios of 1.34 (95% confidence interval (Cl): 1.18-1.52) and 1.77 (95%, Cl: 1.53-2.06) respectively Men with hypogonadotrophic hypogonadism (total testosterone < 8 nmol/l, LH <= 12 IU/l) had the highest prevalence of metabolic syndrome (53%. P<0.001). Conclusions: Lower SHBG is more strongly associated with metabolic syndrome than lower total testosterone in community-dwelling older men. SHBG may be the primary driver of these relationships, possibly reflecting its relationship with insulin sensitivity. Further studies should examine whether measures that raise SHBG protect against the development of metabolic syndrome in older men.
引用
收藏
页码:785 / 792
页数:8
相关论文
共 42 条
[21]   Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men [J].
Laaksonen, DE ;
Niskanen, L ;
Punnonen, K ;
Nyyssönen, K ;
Tuomainen, TP ;
Valkonen, VP ;
Salonen, R ;
Salonen, JT .
DIABETES CARE, 2004, 27 (05) :1036-1041
[22]   Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men:: cross-sectional data from a healthy male cohort [J].
Leifke, E ;
Gorenoi, V ;
Wichers, C ;
von zur Mühlen, A ;
von Büren, E ;
Brabant, G .
CLINICAL ENDOCRINOLOGY, 2000, 53 (06) :689-695
[23]   Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays [J].
Ly, LP ;
Handelsman, DJ .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152 (03) :471-478
[24]   Association between hormones and metabolic syndrome in older Italian men [J].
Maggio, Marcello ;
Lauretani, Fulvio ;
Ceda, Gian Paolo ;
Bandinelli, Stefania ;
Basaria, Shehzad ;
Ble, Alessandro ;
Egan, Josephine ;
Paolisso, Giuseppe ;
Najjar, Samer ;
Metter, E. Jeffrey ;
Valenti, Giorgio ;
Guralnik, Jack M. ;
Ferrucci, Luigi .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (12) :1832-1838
[25]   Hypogonadism and metabolic syndrome: Implications for testosterone therapy [J].
Makhsida, N ;
Shah, J ;
Yan, G ;
Fisch, H ;
Shabsigh, R .
JOURNAL OF UROLOGY, 2005, 174 (03) :827-834
[26]   Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men [J].
Morley, JE ;
Kaiser, FE ;
Perry, HM ;
Patrick, P ;
Morley, PMK ;
Stauber, PM ;
Vellas, B ;
Baumgartner, RN ;
Garry, PJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (04) :410-413
[27]   Endogenous sex hormones and metabolic syndrome in aging men [J].
Muller, M ;
Grobbee, DE ;
den Tonkelaar, I ;
Lamberts, SWJ ;
van der Schouw, YT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) :2618-2623
[28]   Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm [J].
Norman, PE ;
Jamrozik, K ;
Lawrence-Brown, MM ;
Le, MTQ ;
Spencer, CA ;
Tuohy, RJ ;
Parsons, RW ;
Dickinson, JA .
BRITISH MEDICAL JOURNAL, 2004, 329 (7477) :1259-1262A
[29]   Testosterone and estradiol among older men [J].
Orwoll, E ;
Lambert, LC ;
Marshall, LM ;
Phipps, K ;
Blank, J ;
Barrett-Connor, E ;
Cauley, J ;
Ensrud, K ;
Cummings, S ;
Osteoporotic Fractures Men Study Grp .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (04) :1336-1344
[30]   Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men [J].
Osuna, J. A. ;
Gomez-Perez, R. ;
Arata-Bellabarba, G. ;
Villaroel, V. .
ARCHIVES OF ANDROLOGY, 2006, 52 (05) :355-361